Housing, Environment, And Living Conditions for Transformed Health
Launched by UNIVERSITY OF ALABAMA AT BIRMINGHAM · Apr 6, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring how improvements in housing and the environment can affect lung health and chronic diseases. The study will look at three main areas: renovating public housing, enhancing neighborhood conditions, and using indoor air purifiers. Researchers will evaluate how these changes impact people's health behaviors, stress levels, and lung health. They want to find out which approach or combination of approaches works best and how cost-effective they are.
To participate in this study, you need to be at least 18 years old, speak English, and live in one of four public housing sites in Birmingham, Alabama. The trial is not yet recruiting participants, but if you join, you can expect to help researchers understand how your living conditions might affect your health. This information could lead to better support for people living in similar environments.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adults age 18 years and older
- • English speaking
- • Residents of one of 4 public housing site in Birmingham, Alabama
- Exclusion Criteria:
- • Individuals who are not 18 years or older
- • Do not speak English
- • Do not meet the residency criteria
About University Of Alabama At Birmingham
The University of Alabama at Birmingham (UAB) is a prominent academic institution and research hub dedicated to advancing healthcare through innovative clinical trials. Renowned for its commitment to medical discovery and education, UAB conducts cutting-edge research across a wide array of disciplines, including oncology, cardiology, neurology, and public health. With a robust infrastructure for clinical research, UAB fosters collaboration among interdisciplinary teams, leveraging state-of-the-art facilities and resources to enhance the translation of scientific findings into effective treatments and interventions. As a leader in clinical research, UAB aims to improve patient outcomes and contribute to the broader medical community through rigorous trial design and implementation.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Birmingham, Alabama, United States
Patients applied
Trial Officials
Gabriela R Oates, PhD
Principal Investigator
University of Alabama at Birmingham (UAB)
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported